ArticleTherapeutic advances in urology2012

Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: a focus on zoledronic acid.

Matti Aapro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.